Robert Aylesworth, MD
Dermatology · Rhinelander, WINPI 1356397699
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,045 of the $5,817 with a category attached, or 69.5%. 21 manufacturers reported payments, led by Johnson & Johnson at 27.2% of the total.
Across 223 payments — averaging $26.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$935
- Regeneron Healthcare Solutions, Inc.$650
- Lilly USA, LLC$492
- Sanofi$307
- Sun Pharmaceutical Industries Inc.$282
- plus $2K from 15 others
Across 10 payments — averaging $1311.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$13K
What the payments were for
- Consulting fees$1,20021%
- Food & beverage$4,04570%
- Education$57210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $1,582 |
| AbbVie(2 entities) | 58 | $935 |
| Regeneron Healthcare Solutions, Inc. | 21 | $650 |
| Lilly USA, LLC | 37 | $492 |
| Sanofi | 13 | $307 |
| Sun Pharmaceutical Industries Inc. | 12 | $282 |
| Novartis | 15 | $265 |
| E.r. Squibb & Sons, L.L.C. | 12 | $242 |
| Amgen | 8 | $182 |
| Galderma Laboratories, L.p. | 8 | $165 |
| UCB, Inc. | 6 | $164 |
| Janssen Scientific Affairs, LLC | 1 | $150 |
| Genentech USA, Inc. | 5 | $85 |
| Pfizer | 3 | $62 |
| Biofrontera Inc. | 5 | $60 |
| Boehringer Ingelheim | 3 | $51 |
| Bristol Myers Squibb | 2 | $48 |
| Organogenesis Inc. | 2 | $33 |
| Incyte Corporation | 1 | $25 |
| Sandoz | 1 | $19 |
| Genentech, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,817 in reported general payments places this provider in the 85th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $407,201 |
| Taltz AutoinjectorIxekizumab | 40 | $268,964 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $90,508 |
| Dupixent PenDupilumab | 14 | $51,490 |
| Dupixent SyringeDupilumab | 14 | $51,243 |
| Doxycycline Monohydrate | 240 | $7,638 |
| Clobetasol Propionate | 167 | $6,416 |
| Triamcinolone Acetonide | 428 | $4,591 |
| Acitretin | 12 | $2,791 |
| Dapsone | 27 | $2,649 |
| Minoxidil | 121 | $2,301 |
| MethotrexateMethotrexate Sodium | 93 | $2,159 |
| Betamethasone Valerate | 29 | $1,087 |
| Minocycline Hcl | 36 | $1,020 |
| Fluorouracil | 14 | $850 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rhinelander
- David NelsenJanesville$1.1M
- Gabriela MaloneyOconomowoc$725K
- Kenneth GordonWauwatosa$577K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$232K
- Betsy WernliManitowoc$177K
- Daniel OpelSheboygan$118K
- Stephen LewellisPlover$73K
- Patrick SafoStevens Point$53K
- Giacomo MaggiolinoKenosha$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.